Enanta Pharmaceuticals remains a Buy as zelicapavir shows promise in RSV trials; strong financials support growth. Read why ...
We read with interest the Article by Mitsue Saito and colleagues.1 The study showed that adding 5 mg olanzapine after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback